Industry Insights
A Conversation With Professor Josef Penninger on the Journey to a COVID-19 Therapeutic
Industry InsightThe ACE2 receptor has garnered significant attention for the wrong reasons over recent months. Could it point towards an exit route out of this pandemic? In an interview with Technology Networks, the renowned immunologist Professor Josef Penninger explains why he thinks so, and discusses the latest clinical data obtained from testing the soluble ACE2 receptor, APN01.
Read More
How Can Healthcare Workers Keep Up With the Latest Research?
Industry InsightBetween caring for patients and battling global pandemics, healthcare workers have a lot on their plate. How can healthcare workers make time to keep abreast of the latest literature in their field?
Read More
LAMP-Based Testing for COVID-19
Industry InsightTechnology Networks recently spoke to Dr Gary Keating, Chief Technical Officer at Hibergene Diagnostics, to learn more about LAMP technology and the advantages it could offer for COVID-19 testing. Gary also discussed some of the challenges faced when developing diagnostics and how the COVID-19 pandemic has impacted diagnostic design and manufacturing.
Read More
COVID-19 Antibody Testing: S vs. N Protein
Industry InsightTechnology Networks spoke to Dr Iswariya Venkataraman, Scientific Affairs Lead at EUROIMMUN US, to learn about the differences between the S and N proteins and what makes them suitable as target antigens in serology testing. Iswariya also discussed the findings and implications from a study which cautioned against the extensive use of tests that detect antibodies against the N protein only.
Read More
From Vaccine Printers to DNA Data Storage, What's in Store for the Future of Synthetic Biology?
Industry InsightScientists are harnessing the power of synthetic biology – a field of science that involves redesigning biological components to generate novel synthetic entities – to solve scientific problems and drive innovation in medicine. Technology Networks recently spoke with Codex DNA’s CEO Todd R. Nelson to learn about the impact synthetic biology techniques are having on pharmaceutical development and the "big trends" in synthetic biology we are already seeing and are expected to see in the next few years.
Read More
Using Organoids in the Study of Infectious Diseases
Industry InsightBy providing greater physiologic relevance and a species- or patient-specific test platform, organoids overcome many limitations of conventional 2D cultures and even live-animal disease models.
Read More
Exploring SARS-CoV-2 Antibody Testing
Industry InsightTechnology Networks spoke to Jeff Hawkins, Dr Jerry Yeo, and Dr Abhijit Datta, to learn how the information provided by antibody tests can be used appropriately during the COVID-19 pandemic.
Read More
Which COVID-19 Vaccines Are in Human Clinical Trials?
Industry InsightA hub page dedicated to bringing you the latest updates on which COVID-19 vaccines are in human clinical trials.
Read More
Tapping Into Information Locked in Our T Cells To Fight COVID-19
Industry InsightT cells are an important part of our immune memory and offer a wealth of valuable information about the way our bodies perceive and respond to pathogens. Learn how this information is being harnessed and applied in the fight against COVID-19.
Read More
Why Automation Will be the Cornerstone of the Post-COVID Biology Lab
Industry InsightThe 21st century has seen a revolution in how we approach research. With the advent of new technologies like automation and machine/deep learning, biology is becoming a less inferential and more data-driven discipline. With scientific research delayed worldwide due to the COVID-19 pandemic, is it time to re-examine the future role of automation in biological research?
